Sara Abdelfatah
- Co-authors
- Thomas EfferthJanine NaßNuha MahmoudEdmond FleischerVictor KueteAnette KlingerAlexander PanossianGodloves Fru
- Topics
- Computational Drug Discovery Methods (8 papers)Natural product bioactivities and synthesis (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)
- Cited by
- AgingPharmacologyToxicology
- Journals
- SHILAP Revista de lepidopterologíaMoleculesJournal of Ethnopharmacology
In The Last Decade
Sara Abdelfatah
30 papers receiving 607 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 367
- Oncology 109
- Cancer Research 79
- Pharmacology 79
- Pharmacology 79
Countries citing papers authored by Sara Abdelfatah
This map shows the geographic impact of Sara Abdelfatah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Abdelfatah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Abdelfatah more than expected).
Fields of papers citing papers by Sara Abdelfatah
This network shows the impact of papers produced by Sara Abdelfatah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Abdelfatah. The network helps show where Sara Abdelfatah may publish in the future.
Co-authorship network of co-authors of Sara Abdelfatah
This figure shows the co-authorship network connecting the top 25 collaborators of Sara Abdelfatah. A scholar is included among the top collaborators of Sara Abdelfatah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Abdelfatah. Sara Abdelfatah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | 18 | |
| 7 | 19 | |
| 8 | 78 | |
| 9 | 28 | |
| 10 | 3 | |
| 11 | 22 | |
| 12 | 21 | |
| 13 | 42 | |
| 14 | 16 | |
| 15 | 10 | |
| 16 | 30 | |
| 17 | 26 | |
| 18 | 38 | |
| 19 | 17 | |
| 20 | 60 |
About Sara Abdelfatah
Sara Abdelfatah is a scholar working on Aging, Complementary and alternative medicine and Pharmacology, having authored 32 papers that have together received 621 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (8 papers), Natural product bioactivities and synthesis (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Aging (19 citations), Pharmacology (79 citations) and Toxicology (30 citations). Sara Abdelfatah has collaborated with scholars based in Germany, Cameroon and Japan. Frequent co-authors include Thomas Efferth, Janine Naß, Nuha Mahmoud, Edmond Fleischer, Victor Kuete, Anette Klinger, Alexander Panossian, Godloves Fru, Angela Berg and Armelle T. Mbaveng. Their work appears in journals such as SHILAP Revista de lepidopterología, Molecules and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.